Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jeffrey R. Lewis"'
Autor:
Jeffrey R. Lewis, Hagit Ephrath, Olga Sherrod, Stanley A. Cohen, Ian M. Gralnek, Tamara Gobin, Angela Napier
Publikováno v:
Digestive Diseases and Sciences. 57:465-471
Accurately classifying inflammatory bowel disease (IBD) type in pediatric patients may impact medical decision-making, direct therapy, and improve outcomes. This was a prospective cohort study evaluating classification of IBD and patient management w
Autor:
Smruti R. Mohanty, Jeffrey R. Lewis
Publikováno v:
Digestive Diseases and Sciences. 55:560-578
The spectrum of nonalcoholic fatty liver disease (NAFLD) ranges from asymptomatic steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Hepatic steatosis occurs when free fatty acids, released in the setting of insulin resistance and the me
Autor:
Jeffrey R. Lewis, Yuki Young
Publikováno v:
Mount Sinai Expert Guides: Gastroenterology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::980dbd114cc418c3e55eb4382d1cfb15
https://doi.org/10.1002/9781118932759.ch29
https://doi.org/10.1002/9781118932759.ch29
Autor:
JOHN A. BUKOWSKI, JEFFREY R. LEWIS
Publikováno v:
Southern Medical Journal. 93:371-374
Publikováno v:
ICFP
Based on our experience with modelling and verifying microarchitectural designs within Haskell, this paper examines our use of Haskell as host for an embedded language. In particular, we highlight our use of Haskell's lazy lists, type classes, lazy s
Autor:
Jeffrey R Lewis, Lawrence B. Cohen
Publikováno v:
Expert review of gastroenterologyhepatology. 7(1)
The advent of optical colonoscopy has enabled gastroenterologists to visualize the colonic mucosa. This procedure has since become the cornerstone of colon cancer screening programs. Clinicians and scientists have made great strides to fine-tune the
Autor:
Jeffrey R. Lewis, David T. Rubin, Hannah L. Turner, Stephen B. Hanauer, Laura Harrell, Russell D. Cohen
Publikováno v:
Inflammatory bowel diseases. 18(1)
Background: Pivotal trials for adalimumab (ADA) demonstrated effectiveness versus placebo for induction and maintenance of remission in moderate to severely active Crohn's disease (CD). Although the approved maintenance regimen in the U.S. is 40 mg s
Publikováno v:
Genetic testing and molecular biomarkers. 13(4)
Inflammatory bowel disease (IBD) is a chronic gastrointestinal illness with complex genetic underpinnings. Genetic testing for IBD, in particular, for high-risk alleles, is not currently used in clinical practice. Further, preferences and concerns of
Autor:
Smruti R. Mohanty, Brian K. Gehlbach, Jeffrey R. Lewis, Aytekin Oto, Jennifer Chennat, Helen S. Te
Publikováno v:
Nature reviews. Gastroenterologyhepatology. 6(4)
This article considers the case of a 66-year-old white man who presented with a productive cough and pleuritic chest pain on his right side 6 months after undergoing transarterial chemoembolization for hepatocellular carcinoma. The patient was diagno
Autor:
Gareth S. Dulai, Dennis M. Jensen, Gustavo A. Machicado, Thomas O. Kovacs, Gordon V. Ohning, Kevin A. Ghassemi, Jeffrey R. Lewis
Publikováno v:
Gastrointestinal Endoscopy. 81:AB152